Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-04

Clinical Trial Update: Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating quetiapine XR in combination with pramipexole dihydrochloride for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)
  • SEROQUEL XR (Quetiapine)

Snippet

Sponsor: Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc. | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED